Skip to content

AMP Capital Investors Ltd: TRGP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of AMP Capital Investors Ltd on TRGP, newest first. How the timeline and the estimate are built.

AMP Capital Investors Ltd held 0 TRGP shares at 2022-03-31 per its 13F-HR filed 2022-05-16.

the latest 13F is the newest step

  1. period ended2022-03-31
    13F 0 shares
    Change vs previous 13F -249,795 shares

    13F-HR 0001085146-22-002153 filed by AMP Capital Investors Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2021-12-31
    13F 249,795 shares
    Change vs previous 13F -92,063 shares

    0.37% of the 13F portfolio, value $13,031,000.

    13F-HR 0001085146-22-000966 filed by AMP Capital Investors Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-09-30
    13F 341,858 shares
    Change vs previous 13F +253,712 shares

    0.09% of the 13F portfolio, value $16,840,000.

    13F-HR 0001085146-21-003223 filed by AMP Capital Investors Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-06-30
    13F 88,146 shares
    Change vs previous 13F -23,487 shares

    0.02% of the 13F portfolio, value $3,897,000.

    13F-HR 0001085146-21-002508 filed by AMP Capital Investors Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-03-31
    13F 111,633 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $3,548,000.

    13F-HR 0001085146-21-001721 filed by AMP Capital Investors Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).